Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 100

Similar articles for PubMed (Select 16511429)

1.

Enfurvitide prevents vertical transmission of multidrug-resistant HIV-1 in pregnancy but does not cross the placenta.

Brennan-Benson P, Pakianathan M, Rice P, Bonora S, Chakraborty R, Sharland M, Hay P.

AIDS. 2006 Jan 9;20(2):297-9.

PMID:
16511429
2.

Successful prevention of multidrug resistant HIV mother-to-child transmission with enfuvirtide use in late pregnancy.

Madeddu G, Calia GM, Campus ML, Lovigu C, Mannazzu M, Olmeo P, Mela MG, Mura MS.

Int J STD AIDS. 2008 Sep;19(9):644-5. doi: 10.1258/ijsa.2008.008100.

PMID:
18725561
3.

Perinatal transmission of multidrug-resistant HIV-1 despite viral suppression on an enfuvirtide-based treatment regimen.

Cohan D, Feakins C, Wara D, Petru A, McNicholl I, Schillinger D, Lu J, Kuritzkes D, Deeks SG.

AIDS. 2005 Jun 10;19(9):989-90. No abstract available.

PMID:
15905684
4.

Prevention of mother-to-child transmission of multi-drug resistant HIV-1 using maternal therapy with both enfuvirtide and tipranavir.

Wensing AM, Boucher CA, van Kasteren M, van Dijken PJ, Geelen SP, Juttmann JR.

AIDS. 2006 Jun 26;20(10):1465-7. No abstract available.

PMID:
16791028
5.

Pharmacokinetics of antiretroviral drugs in anatomical sanctuary sites: the fetal compartment (placenta and amniotic fluid).

Else LJ, Taylor S, Back DJ, Khoo SH.

Antivir Ther. 2011;16(8):1139-47. doi: 10.3851/IMP1918. Review.

PMID:
22155898
6.

Enfuvirtide prescription at the end of pregnancy to a multi-treated HIV-infected woman with virological breakthrough.

Meyohas MC, Lacombe K, Carbonne B, Morand-Joubert L, Girard PM.

AIDS. 2004 Sep 24;18(14):1966-8. No abstract available.

PMID:
15353987
7.

Genotypic resistance tests for the management of the HIV-infected pregnant woman.

Bassetti D, Cargnel A.

Scand J Infect Dis Suppl. 2003;106:70-4. Review.

PMID:
15000589
8.

Achieving rapid reduction of HIV-1 viral load in HIV-positive pregnant women close to term - an obstetric/medical emergency: a review of three cases.

Adeyemo A, Wood C, Govind A.

Int J STD AIDS. 2013 Jul;24(7):591-2. doi: 10.1177/0956462413476275. Epub 2013 Jul 4.

PMID:
23970779
9.

Antiretroviral therapy (ART) for treating HIV infection in ART-eligible pregnant women.

Sturt AS, Dokubo EK, Sint TT.

Cochrane Database Syst Rev. 2010 Mar 17;(3):CD008440. doi: 10.1002/14651858.CD008440. Review.

PMID:
20238370
10.

Use of darunavir and enfuvirtide in a pregnant woman.

Sued O, Lattner J, Gun A, Patterson P, Abusamra L, Cesar C, Fink V, Krolewiecki A, Cahn P.

Int J STD AIDS. 2008 Dec;19(12):866-7. doi: 10.1258/ijsa.2008.008075.

PMID:
19050223
11.

[Enfuvirtide, mechanism of action and pharmacological properties].

Kapić E, Becić F, Zvizdić S.

Med Arh. 2005;59(5):313-6. Review. Bosnian.

PMID:
16134757
12.

Enfuvirtide, a new drug for HIV infection.

Fletcher CV.

Lancet. 2003 May 10;361(9369):1577-8. No abstract available.

PMID:
12747873
13.

Quantifying the impact of nevirapine-based prophylaxis strategies to prevent mother-to-child transmission of HIV-1: a combined pharmacokinetic, pharmacodynamic, and viral dynamic analysis to predict clinical outcomes.

Frank M, von Kleist M, Kunz A, Harms G, Schütte C, Kloft C.

Antimicrob Agents Chemother. 2011 Dec;55(12):5529-40. doi: 10.1128/AAC.00741-11. Epub 2011 Sep 26.

14.

Survival of HIV-1 infected multidrug-resistant patients recycling enfuvirtide after a previous failure.

Cossarini F, Galli L, Sagnelli C, Gianotti N, Hasson H, Clementi M, Soria A, Salpietro S, Lazzarin A, Castagna A.

J Acquir Immune Defic Syndr. 2009 Jun 1;51(2):179-84. doi: 10.1097/QAI.0b013e3181a56f46.

PMID:
19352200
15.

Decreased plasma levels of darunavir/ritonavir in a vertically infected pregnant woman carrying multiclass-resistant HIV type-1.

Pinnetti C, Tamburrini E, Ragazzoni E, De Luca A, Navarra P.

Antivir Ther. 2010;15(1):127-9. doi: 10.3851/IMP1473.

PMID:
20167999
16.

Inhibition of HIV-1 group M and O isolates by fusion inhibitors.

Chinnadurai R, Münch J, Dittmar MT, Kirchhoff F.

AIDS. 2005 Nov 4;19(16):1919-22.

PMID:
16227804
17.

[Use of enfurvitide in pregnancy in HIV positive women in seven cases].

Jeantils V, Alloui C, Rodrigues A, Bentata M, Peytavin G, Carbillon L.

Gynecol Obstet Fertil. 2009 May;37(5):396-400. doi: 10.1016/j.gyobfe.2009.03.013. Epub 2009 Apr 23. French.

PMID:
19398364
18.

[Strategies for combating resistances in HIV therapy--an exemplifying case].

Stoehr A.

MMW Fortschr Med. 2004 Apr 26;146 Spec No 1:70-1. German. No abstract available.

PMID:
15373056
19.

Drug profile: enfuvirtide (Fuzeon, ENF, T-20).

Pham PA.

Hopkins HIV Rep. 2003 May;15(3):1-2. No abstract available.

PMID:
12809104
20.

Drug resistance among HIV-infected pregnant women receiving antiretrovirals for prophylaxis.

Duran AS, Losso MH, Salomón H, Harris DR, Pampuro S, Soto-Ramirez LE, Duarte G, de Souza RS, Read JS; NISDI Perinatal Study Group.

AIDS. 2007 Jan 11;21(2):199-205.

PMID:
17197811
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk